To identify the functional downstream receptors of VEGF-A in CD4 CTLs with increased cytotoxicity, CD4+ T cells from GO patients were treated with anti-VEGF-R1/R2 neutralizing antibodies. The gene discussed is VEGFA; the disease is geroderma osteodysplastica.